Glaukos CorpHere is the public summary page for Glaukos Corp. Please login to see the complete information for Glaukos Corp including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Glaukos Corp stacks up relative to its peers. |
| Darwin Score | 0 |
| Ticker | GKOS |
| Latest Price | 98.50 USD as of close on 16-Jul-2025 |
| 3 Month price range | 83.54 to 106.55 USD |
| Market Capitalisation | 5.61Bn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Health Care Equipment & Services |
| Industry | Health Care Equipment & Supplies |
| Sub-Industry | Health Care Equipment |
| Description | Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The company offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. It also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; iAccess, a precision blade; and iPRIME, a viscoelastic delivery system. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California. See More ... |
| Company URL | https://www.glaukos.com |
| See Darwins Full Analysis for Glaukos Corp |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Glaukos Corp. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -6 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -6 |
| Flow | Institutional, Fund and Insider buying and selling. | -8 |
| Models | Forecast models. | +20 |
Alerts
There are 7 live alerts for Glaukos Corp.
- Divergence: Px Up & 30d RSI Down last 20 days. This alert has occurred 38 times over the last last year. The average forward returns are -0.6% over 5 days, 0.6% over 10 days, -0.5% over 15 days and -2.2% over 20 days. (Negative)
- Divergence: Px Up & 15d RSI Down last 20 days. This alert has occurred 48 times over the last last year. The average forward returns are 0.0% over 5 days, 1.2% over 10 days, 0.3% over 15 days and -0.9% over 20 days. (Negative)
- Cross Over (Down): 20dma . This alert has occurred 19 times over the last last year. The average forward returns are 2.1% over 5 days, 1.6% over 10 days, 0.5% over 15 days and 1.3% over 20 days. (Negative)
- Oversold - The 5 day RSI is +20.0. (Positive)
- Divergence: Px Down & OBV Up last 20 days. This alert has occurred 94 times over the last last year. The average forward returns are -1.0% over 5 days, -2.6% over 10 days, -3.0% over 15 days and -3.5% over 20 days. (Positive)
- Divergence: Px Down & OBV Up last 10 days. This alert has occurred 110 times over the last last year. The average forward returns are 0.0% over 5 days, -0.2% over 10 days, -1.4% over 15 days and -1.9% over 20 days. (Positive)
- 5d RSI Oversold. This alert has occurred 52 times over the last last year. The average forward returns are 0.0% over 5 days, -1.0% over 10 days, -1.8% over 15 days and -4.1% over 20 days. (Negative)
Peer Comparison
There are 17 peers of Glaukos Corp.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Abbott Laboratories (ABT) | Health Care Equipment | +29 |
| Artivion Inc (AORT) | Health Care Equipment | +24 |
| Baxter International Inc (BAX) | Health Care Equipment | -21 |
| Becton Dickinson and Co (BDX) | Health Care Equipment | +9 |
| Boston Scientific Corp (BSX) | Health Care Equipment | +21 |
| Conmed Corp (CNMD) | Health Care Equipment | -5 |
| Danaher Corp (DHR) | Health Care Equipment | -3 |
| Edwards Lifesciences Corp (EW) | Health Care Equipment | +19 |
| Enovis Corp (ENOV) | Health Care Equipment | -29 |
| Globus Medical Inc (GMED) | Health Care Equipment | +5 |
| Integer Holdings Corp (ITGR) | Health Care Equipment | +5 |
| Penumbra Inc (PEN) | Health Care Equipment | -17 |
| Resmed Inc (RMD) | Health Care Equipment | +27 |
| Solventum Corp (SOLV) | Health Care Equipment | +16 |
| Stryker Corp (SYK) | Health Care Equipment | +42 |
| Teleflex Inc (TFX) | Health Care Equipment | -28 |
| Zimmer Biomet Holdings Inc (ZBH) | Health Care Equipment | +13 |
Share 
